Oral Presentation-1
|
13:30-15:30 新闻发布厅C |
|---|
| 主持 Moderators | 韦铁民 Tiemin WEI, 徐晟杰 Chengjie XU, 何承满 Chengman HE | ||
|
13:30-13:40 |
Resting IL-6 Levels Predict Myocardial Perfusion Deficits Under Mental Stress | 常金娜 Jinna CHANG | |
|
13:40-13:45 |
讨论 | ||
|
13:45-13:55 |
Interpretable Machine Learning for Identifying Predictive Features of High-Risk Heart Failure Hospitalization in Patients with HFpEF and Symptomatic Aortic Stenosis Following TAVR: A Multicenter Study | 王钧 Jun WANG | |
|
13:55-14:00 |
讨论 | ||
|
14:00-14:10 |
The Comparative Analyses Between Conventional Metallic Occluders and Fully Absorbable Occluders Implementing the Most Innovative Minimally Invasive Surgical Transcatheter Treatments for Congenital Heart Diseases | Rajbhandari SUDHIR SUDHIR Rajbhandari | |
|
14:10-14:15 |
讨论 | ||
|
14:15-14:25 |
Subendocardium-involved LGE as an Underrecognized Pattern Associated with Sudden Cardiac Death in Dilated Cardiomyopathy | 贾溪 Xi JIA | |
|
14:25-14:30 |
讨论 | ||
|
14:30-14:40 |
Steatotic Liver Disease and Fibrosis associated with risk of atherosclerotic cardiovascular Disease in Chinese Adults Steatotic liver disease and fibrosis associated with risk of atherosclerotic cardiovascular disease in Chinese adults |
刘琼 Qiong LIU | |
|
14:40-14:45 |
讨论 | ||
|
14:45-14:55 |
The Feasibility and Utility of Large Language Models in Interpreting Cardiac Magnetic Resonance Report | 撒芬 Fen SA | |
|
14:55-15:00 |
讨论 | ||
|
15:00-15:10 |
Sex Differences in Clinical Characteristics and Outcomes in Subjects with Left Ventricular Hypertrabeculation | 李好 Hao LI | |
|
15:10-15:15 |
讨论 | ||
|
15:15-15:25 |
α-Ketoglutarate Alleviates Hypobaric Hypoxia-Induced Pulmonary Hypertension via Suppression of Pulmonary Artery Smooth Muscle Cell Proliferation and Induction of Programmed Cell Death | 李浩然 Haoran LI | |
|
15:25-15:30 |
讨论 | ||
Oral Presentation-2
|
15:30-17:15 新闻发布厅C |
|---|
| 主持 Moderators | 王宁夫 Ningfu WANG, 张轩 Xuan ZHANG, 王孝雅 Xiaoya WANG | ||
|
15:30-15:40 |
CAATSR: A Novel Senescence-Promoting Transfer RNA-derived Small RNA in Cardiac Aging | 马焱 Yan MA | |
|
15:40-15:45 |
讨论 | ||
|
15:45-15:55 |
Superlubricious Dapagliflozin-loaded PDMC-PCM Nanoparticles Boost Therapeutic Effects in Diabetic Myocardial Infarction: Mitochondrial Repair and Targeted Delivery Synergy | 杨雁如 Yanru YANG | |
|
15:55-16:00 |
讨论 | ||
|
16:00-16:10 |
From Pixels to Fibers: MD-CTA Derived Aortic Wall Mechanics Predict Elastin-Collagen Composition in Aortic Aneurysm | 黄天明 Tianming HUANG | |
|
16:10-16:15 |
讨论 | ||
|
16:15-16:25 |
Label-free TPEF/SHG imaging identifes advanced atherosclerotic lesions by quantifying fiber content and arrangement: from rabbit model to human study | 马明睿 Mingrui MA | |
|
16:25-16:30 |
讨论 | ||
|
16:30-16:40 |
The effect of DUSP1 ADP-ribosylation-mediated p38 MAPK phosphorylation on reversing metabolic reprogramming promotes cardiomyocyte proliferation and heart regeneration | 唐陆勋 Luxun TANG | |
|
16:40-16:45 |
讨论 | ||
|
16:45-16:55 |
Targeted PTGS2 Activation: A Flow-Responsive Nanodisk Strategy for Atherosclerosis Therapy | 张辰 Chen ZHANG | |
|
16:55-17:00 |
讨论 | ||
|
17:00-17:10 |
Explainable Machine-Learning Model Predicts Long-Term Ischemic Stroke After Non-ST-Elevation Acute Coronary Syndrome in Type 2 Diabetes: A Nationwide Multicenter Cohort Study | 杨晓萌 Xiaomeng YANG | |
|
17:10-17:15 |
讨论 | ||
Atrial Fibrillation and Antithrombosis Forum-1
|
13:30-15:30 新闻发布厅C |
|---|
| 主持 Moderators | Gregory LIP, 张萍 Ping ZHANG, 刘喜 Xi LIU, 薛智敏 Zhimin XUE, 杜飚 Biao DU | ||
|
13:30-13:50 |
房颤负荷与卒中风险的再认识 Atrial Fibrillation Burden and Stroke Risk: Revisited |
郦明芳 Mingfang LI | |
|
13:50-14:10 |
房颤导管消融治疗的最佳时间 Optimal Timing for Catheter Ablation in Atrial Fibrillation Treatment |
杨新春 Xinchun YANG | |
|
14:10-14:30 |
缺血性脑卒中：LAAO与OAC孰优孰劣？ Ischemic Stroke: LAAO or OAC, Which Is Superior? |
苏晞 Xi SU | |
|
14:30-14:50 |
亚临床房颤抗栓治疗的药物选择 Antithrombotic Choice in Subclinical Atrial Fibrillation |
郭豫涛 Yutao GUO | |
|
14:50-15:10 |
中医药在房颤抗栓及预防复发中的应用与机制 Traditional Chinese Medicine: Its Role and Mechanisms in Thromboprophylaxis and Relapse Prevention for Atrial Fibrillation |
池菊芳 Jufang CHI | |
|
15:10-15:30 |
讨论 Discussion |
||
Atrial Fibrillation and Antithrombosis Forum-2
|
15:30-17:30 新闻发布厅C |
|---|
| 主持 Moderators | 洪葵 Kui HONG, 许顶立 Dingli XU, 佟倩 Qian TONG, 杜先锋 Xianfeng DU, 方丹红 Danhong FANG | ||
|
15:30-15:50 |
艾多沙班单药治疗：房颤合并稳定型冠心病患者长期抗栓治疗的新选择 —EPIC-CAD 研究启示 Edoxaban Monotherapy: A New Antithrombotic Strategy for Patients with AF and Stable CAD — Insights from the EPIC-CAD Trial |
Duk-Woo PARK | |
|
15:50-16:10 |
AI 赋能的影像筛查：缺血性卒中后潜在房颤的识别与抗栓策略优化 Leveraging AI-Powered Imaging to Identify Underlying Atrial Fibrillation and Optimize Antithrombotic Strategy After Ischemic Stroke |
黄冬 Dong HUANG | |
|
16:10-16:30 |
急性缺血性卒中合并房颤的抗凝时机：1-3-6-12 原则 vs. 早期（≤4 天）启动 Timing of Anticoagulation in Acute Ischemic Stroke with Atrial Fibrillation: The ‘1-3-6-12-Day Rule’ versus Early Initiation (≤4 Days) |
赵性泉 Xingquan ZHAO | |
|
16:30-16:50 |
ICE在左心耳封堵术中的应用及与TEE对比 Intracardiac Echocardiography versus Transesophageal Echocardiography in Left Atrial Appendage Occlusion |
刘喜 Xi LIU | |
|
16:50-17:10 |
房颤管理：遵循ABC路径看似简单 Management of Atrial Fibrillation: Easy as ABC, or is it a ‘SOS’ or do we ‘Handle with CARE’ |
Gregory LIP | |
|
17:10-17:30 |
讨论 Discussion |
||
Non-invasive CV Imaging Forum-1 心血管影像技术的融合与转化 - 聚焦CMR与CT的精准功能学评估
|
08:00-10:00 新闻发布厅C |
|---|
| 主席 Chairman | 赵世华 Shihua ZHAO | ||
| 主持 Moderators | Swee Yaw TAN, Mei-Yi CHAN | ||
|
08:00-08:20 |
再论基于磁共振组织学特征的病理影像化 MRI-Based Histological Characterization Revisited: Towards Pathological Visualization |
赵世华 Shihua ZHAO | |
|
08:20-08:40 |
光子 CT 冠脉成像在冠心病中的诊断标准建立 Establishing Diagnostic Criteria for Coronary Artery Disease Using Photon-Counting CT Coronary Angiography |
杨文洁 Wenjie YANG | |
|
08:40-09:00 |
4D Flow in CMR Application, from Pathophysiology to Clinical Implication | Liang ZHONG | |
|
09:00-09:20 |
AI in Quantitative CT Myocardial Perfusion Imaging | 张佳胤 Jiayin ZHANG | |
|
09:20-09:40 |
Advances in Automated CMR Analysis | GEEST Rob VAN DER | |
|
09:40-10:00 |
冠脉微循环的研究进展与治疗现状 Research Progress and Treatment Status of Coronary Microcirculation |
宋现涛 Xiantao SONG | |
Non-invasive CV Imaging Forum-2 SCS@QICC联合论坛
|
10:00-12:00 新闻发布厅C |
|---|
| 主席 Chairman | 陆敏杰 Minjie LU | ||
| 主持 Moderators | Liang ZHONG, 林先和 Xianhe LIN, 杨文洁 Wenjie YANG | ||
|
10:00-10:20 |
Coronary Artery Stenosis vs Coronary Atherosclerosis - Time to Change our Thinking? | Y.S. CHANDRASHEKHAR | |
|
10:20-10:40 |
CMR Mapping 技术在心血管疾病中的探索：从风险预测到精准诊疗 CMR Mapping in Cardiovascular Disease: From Risk Prediction to Precision Diagnosis and Therapy |
陆敏杰 Minjie LU | |
|
10:40-11:00 |
法布雷心肌病从影像到基因：构建罕见心脏病的全周期诊疗新范式 Fabry Cardiomyopathy: From Imaging to Gene — Pioneering a New Holistic Management Paradigm for a Rare Heart Disease |
陈玉成 Yucheng CHEN | |
|
11:00-11:20 |
Cardiac CT in Structural Heart Assessments : (TAVI and Beyond) | Swee Yaw TAN | |
|
11:20-11:40 |
Refining Cardiovascular Risk: Calcium Scoring in Primary Prevention and Risk Stratification | Mei-Yi CHAN | |
|
11:40-12:00 |
讨论 | ||
CTO Forum-1
|
13:30-15:30 新闻发布厅C |
|---|
| 主持 Moderators | 方崇峰 Chongfeng FANG, 杨建敏 Jianmin YANG, 朱玲军 Lingjun ZHU, 汪晓敏 Xiaomin WANG, 朱赟 Bin ZHU, 吴新东 Xindong WU | ||
|
13:30-13:50 |
正向技术新进展：从导丝升级到ADR技术的革新 New Progress in Antegrade Technology: Innovation from Guidewire Upgrade to ADR Technology |
聂斌 Bin NIE | |
|
13:50-14:10 |
克制的Knuckle Temperate Knuckle |
杨峻青 Junqing YANG | |
|
14:10-14:30 |
2025年CTO-PCI的适应证：从症状改善到预后获益的最新证据 Indications for CTO-PCI in 2025: Latest Evidence from Symptom Improvement to Prognostic Benefit |
张文斌 Wenbin ZHANG | |
|
14:30-14:50 |
CTA在CTO中的应用 Application of CTA in CTO |
谷国强 Guoqiang GU | |
|
14:50-15:10 |
透视”闭塞病变：IVUS与CCTA指导下的精准CTO介入治疗 “Fluoroscopic” Occlusive Lesions: Precision CTO Interventional Therapy Guided by IVUS and CCTA |
张新民 Xinmin ZHANG | |
|
15:10-15:30 |
讨论 Discussion |
||
CTO Forum-2
|
15:30-17:30 新闻发布厅C |
|---|
| 主持 Moderators | 李妍 Yan LI, 黄朝阳 Chaoyang HUANG, 郑浩 Hao ZHENG, 吴军 Jun WU, 胡海雷 Hailei HU, 吴信雷 Xinlei WU | ||
|
15:30-15:50 |
前向导丝技术：基于CTO病变解剖结构的策略选择 Antegrade Wiring in CTO CTO Anatomy - Decide the Strategy |
Roopali KHANNA | |
|
15:50-16:10 |
CTO病变导丝选择策略 CTO Lesion Guidewire Selection Strategy |
张力 Li ZHANG | |
|
16:10-16:30 |
钙化CTO病变的挑战与对策 Challenges and Strategies for Calcified CTO Lesions |
胡涛 Tao HU | |
|
16:30-16:50 |
Knuckle技术在CTO病变中的应用 The Application of the Knuckle Technique in CTO Interventions |
荆全民 Quanmin JING | |
|
16:50-17:10 |
双腔微导管在CTO中的应用 The Utility of Dual-Lumen Microcatheters in CTO Percutaneous Coronary Intervention |
王齐增 Qizeng WANG | |
|
17:10-17:30 |
讨论 Discussion |
||
Pacing Forum-6 再同步化起搏
|
08:00-10:00 新闻发布厅C |
|---|
| 主持 Moderators | 郑良荣 Liangrong ZHENG, 江建军 Jianjun JIANG, 李嘉 Jia LI, 金奇志 Qizhi JIN | ||
| 讨论嘉宾 Discussants | 孙启银 Qiyin SUN, 吴丹宁 Danning WU, 马宏 Hong MA, 辛卫朋 Weipeng XIN | ||
|
08:00-08:20 |
左室四极导线的临床应用进展 Clinical Application Progress of Left Ventricular Quadripolar Leads |
禹子清 Ziqing YU | |
|
08:20-08:40 |
最新植入工具在crt植入中的临床应用 Clinical Application of Latest Implantation Tools in CRT Implantation |
蓝荣芳 Rongfang LAN | |
|
08:40-09:00 |
再同步化治疗：CRTP还是CRTD？ Resynchronization Therapy: CRT-P or CRT-D? |
徐耕 Geng XU | |
|
09:00-09:20 |
CRT植入过程中左室导线常见问题的梳理与解决 Sorting and Solutions to Common Problems of Left Ventricular Leads During CRT Implantation |
李若谷 Ruogu LI | |
|
09:20-09:40 |
心衰合并房颤患者的再同步化治疗策略 Resynchronization Therapy Strategy for Heart Failure Patients Complicated with Atrial Fibrillation |
薛小临 Xiaolin XUE | |
|
09:40-10:00 |
讨论 Discussion |
||
Case Session-Pacing 2
|
10:00-11:30 新闻发布厅C |
|---|
| 主持 Moderators | 李若谷 Ruogu LI, 陈雯艾 Wenai CHEN, 魏文娟 Wenjuan WEI, 金春娜 Chunna JIN, 程云仙 Yunxian CHENG | ||
|
10:00-10:15 |
无导线起搏器非常规回收技术应用一例 | 陈恋 Lian CHEN | |
|
10:15-10:30 |
心房无导线的植入经验分享 | 林小平 Xiaoping LIN | |
|
10:30-10:45 |
三尖瓣成型术后升级CSP一例 | 李支娣 Zhidi LI | |
|
10:45-11:00 |
山重水复疑无路，柳暗花明又一村—一例起搏器患者的求医之路 | 阮文强 Wenqiang RUAN | |
|
11:00-11:15 |
LTAD植入术在难治性心衰合并心律失常中的应用 | 周建中 Jianzhong ZHOU | |
|
11:15-11:30 |
猝死预防新选择—血管外除颤器二级预防应用两例 | 陈涵 Han CHEN | |